INCOP Outlines First Phase Of Billion-Dollar Drug Procurement Plan

BMI View: Ecuador's decision to invest in its ailing public healthcare infrastructure has resulted in higher than expected spending announcements. However, the government's decision to set aside over US$1bn for pharmaceutical spending is likely to sideline foreign drugmakers if the country continues down its path towards increasingly pro-domestic industry policies and protectionist measures.

To read the full article, please choose one of the following options: